Ameri-Tech Kidney Center-Arlington Llc is a medicare approved dialysis facility center in Arlington, Texas and it has 22 dialysis stations. It is located in Tarrant county at 1138 S Bowen Road, Arlington, TX, 76013. You can reach out to the office of Ameri-Tech Kidney Center-Arlington Llc at (817) 265-7115. This dialysis clinic is managed and/or owned by American Renal Associates. Ameri-Tech Kidney Center-Arlington Llc has the following ownership type - Profit. It was first certified by medicare in April, 1990. The medicare id for this facility is 452618 and it accepts patients under medicare ESRD program.
| Name | Ameri-Tech Kidney Center-Arlington Llc |
|---|---|
| Location | 1138 S Bowen Road, Arlington, Texas |
| No. of Dialysis Stations | 22 |
| Medicare ID | 452618 |
| Managed By | American Renal Associates |
| Ownership Type | Profit |
| Late Shifts | No |
| 1138 S Bowen Road, Arlington, Texas, 76013 | |
| (817) 265-7115 | |
News Archive
In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.
Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.
Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
› Verified 5 days ago
| NPI Number | 1801995584 |
| Doing Business As | Ameri-tech Kidney Center |
| Address | 1138 S Bowen Rd Arlington, Texas, 76013 |
| Phone Number | (817) 265-7115 |
News Archive
In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.
Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.
Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
› Verified 5 days ago
| NPI Number | 1912345794 |
| Doing Business As | Ameri-tech Kidney Center-arlington Llc |
| Address | 1138 S Bowen Rd Arlington, Texas, 76013 |
| Phone Number | (817) 265-7115 |
News Archive
In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.
Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.
Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 59% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 19% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 22% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 57% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 30% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 13% | 14% |
News Archive
In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.
Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.
Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 52% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 22% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 26% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 42% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 33% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 25% | 12% |
News Archive
In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.
Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.
Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 81% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 19% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 51% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 18% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 31% | 12% |
News Archive
In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.
Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.
Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 57 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 56 |
News Archive
In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.
Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.
Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 99 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 854 |
| Percentage of adult patients getting regular hemodialysis at the center | 94 |
News Archive
In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.
Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.
Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
› Verified 5 days ago
| Adult patients getting regular peritoneal dialysis at the center | 12 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 93 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 70 |
News Archive
In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.
Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.
Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Ameri-Tech Kidney Center-Arlington Llc with elevated calcium levels.
| Patients with hypercalcemia | 130 |
| Hypercalcemia patient months | 1137 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 2 |
| Patients with Serumphosphor | 137 |
| Patients with Serumphosphor less than 3.5 mg/dL | 8 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 17 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 26 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 31 |
| Patients with Serumphosphor greater than 7 mg/dL | 17 |
News Archive
In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.
Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.
Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 99 |
| Patient months included in arterial venous fistula and catheter summaries | 764 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 63 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 15 |
News Archive
In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.
Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.
Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 117 |
| Hospitalization Rate in facility | 271.7 (Worse than Expected) |
| Hospitalization Rate: Upper Confidence Limit | 407.4 |
| Hospitalization Rate: Lower Confidence Limit | 192.6 |
News Archive
In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.
Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.
Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
› Verified 5 days ago
The rate of readmission show you whether patients who were being treated regularly at Ameri-Tech Kidney Center-Arlington Llc were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 26.6 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 35.5 |
| Readmission Rate: Lower Confidence Limit | 18.6 |
News Archive
In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.
Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.
Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
› Verified 5 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Ameri-Tech Kidney Center-Arlington Llc get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .14 (Better than Expected) |
| SIR: Upper Confidence Limit | .69 |
| SIR: Lower Confidence Limit | .01 |
News Archive
In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.
Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.
Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
› Verified 5 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Ameri-Tech Kidney Center-Arlington Llc's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 91 |
| Transfusion Rate in facility | 98.5 (Worse than Expected) |
| Transfusion Rate: Upper Confidence Limit | 167.8 |
| Transfusion Rate: Lower Confidence Limit | 61.8 |
News Archive
In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.
Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.
Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
› Verified 5 days ago
The rate of mortality show you whether patients who were being treated regularly at Ameri-Tech Kidney Center-Arlington Llc lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 619 |
| Mortality Rate in facility | 23.1 (Worse than Expected) |
| Mortality Rate: Upper Confidence Limit | 28.1 |
| Mortality Rate: Lower Confidence Limit | 18.7 |
News Archive
In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.
Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.
Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
› Verified 5 days ago
Us Renal Care Tarrant Dialysis Arlington Location: 203 W Randol Mill Rd, Arlington, Texas, 76011 Phone: (817) 275-7787 |
South Arlington Dialysis Center Location: 3415 S Cooper Street, Arlington, Texas, 76015 Phone: (817) 465-8585 |
Ameri-Tech Kidney Center-Arlington Llc Location: 1138 S Bowen Road, Arlington, Texas, 76013 Phone: (817) 265-7115 |
News Archive
In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.
Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.
Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
› Verified 5 days ago